Galapagos to present at the 31st annual J. P. Morgan Healthcare Conference
January 6, 2013 - Mechelen, Belgium
Galapagos NV (EURONEXT BRUSSELS: GLPG)announcedtoday that Onno van de Stolpe, CEO of Galapagos, will present at the31(st)annual J. P. Morgan Healthcare Conference on Thursday, January 10(th) at9:00a.m. (PST) / 12 p.m. (EST)/ 18.00 (CET) in San Francisco. Thepresentationwill be held in the Elizabethan A/B room in the Westin St. Francis and willalsobe webcast.
Click here to access the webcast or go to www.glpg.com to access a PDFof thepresentation slides. A replay of the presentation will be availablefor 90days.
About Galapagos
Galapagos (EURONEXT BRUSSELS: GLPG) (PINKSHEETS: GLPYY) is a mid-sizeclinical stagebiotechnology company specialized in the discovery and development ofsmallmolecule and antibody therapies with novel modes-of-action. TheCompany isprogressing its JAK1 inhibitor GLPG0634, as well as one of the largestpipelinesin biotech, with four programs in development and over 30 discoveryprograms.The Galapagos Group has over 800 employees and operates facilities infivecountries, with global headquarters in Mechelen, Belgium. Moreinfo at:www.glpg.com
This release may contain forward-looking statements, including,withoutlimitation, statements containing the words "believes,""anticipates,""expects," "intends," "plans," "seeks," "estimates," "may," "will,""could,""stands to," and "continues," as well as similar expressions. Suchforward-looking statements may involve known and unknown risks, uncertainties andotherfactors which might cause the actual results, financial condition,performanceor achievements of Galapagos, or industry results, to be materiallydifferentfrom any historic or future results, financial conditions,performance orachievements expressed or implied by such forward-looking statements.Giventhese uncertainties, the reader is advised not to place any unduereliance onsuch forward-looking statements. These forward-looking statements speakonly asof the date of publication of this document. Galapagos expresslydisclaims anyobligation to update any such forward-looking statements in thisdocument toreflect any change in its expectations with regard thereto or anychange inevents, conditions or circumstances on which any such statement is based,unlessrequired by law or regulation.
This announcement is distributed by Thomson Reuters on behalf ofThomson Reuters clients. The owner of this announcement warrants that:(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Galapagos NV via Thomson Reuters ONE[HUG#1668408]
CONTACT
Galapagos NV
Elizabeth Goodwin
Director Investor Relations
Tel: +31 6 2291 6240
Email Contact
